Gabriella Giancane
Overview
Explore the profile of Gabriella Giancane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
819
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Straalen J, Baas L, Giancane G, Grebenkina L, Brunner J, Vega-Cornejo G, et al.
Pediatr Rheumatol Online J
. 2023 Feb;
21(1):19.
PMID: 36810111
Background: Little is known about the association between juvenile idiopathic arthritis (JIA) and autoimmune thyroid disease (AITD) and therefore there are no indications for AITD screening in this population, which...
2.
van Straalen J, de Roock S, Giancane G, Alexeeva E, Koskova E, Mesa-Del-Castillo Bermejo P, et al.
Pediatr Rheumatol Online J
. 2022 Nov;
20(1):103.
PMID: 36401230
Background: Little is known about the disposition to autoimmune diseases (ADs) among children diagnosed with JIA. In this study, we provide a comprehensive overview of the prevalence of and factors...
3.
van Straalen J, de Roock S, Giancane G, Consolaro A, Rygg M, Nordal E, et al.
Pediatr Rheumatol Online J
. 2022 Nov;
20(1):96.
PMID: 36376976
Background: Etanercept (ETN) and adalimumab (ADA) are considered equally effective biologicals in the treatment of arthritis in juvenile idiopathic arthritis (JIA) but no studies have compared their impact on patient-reported...
4.
Rosina S, Giancane G, Ruperto N
Expert Opin Investig Drugs
. 2022 Sep;
31(10):1109-1124.
PMID: 36066506
Introduction: Juvenile idiopathic arthritis (JIA) is the most common chronic inflammatory rheumatic condition in childhood. The management of JIA has been revolutionized thanks to the development of new powerful drugs...
5.
Alongi A, Giancane G, Naddei R, Natoli V, Ridella F, Burrone M, et al.
RMD Open
. 2022 Mar;
8(1).
PMID: 35256534
Objective: To investigate the frequency in which the physician provides a global assessment of disease activity (PhGA) >0 and an active joint count (AJC)=0 in children with juvenile idiopathic arthritis...
6.
Giancane G, Papa R, Vastert S, Bagnasco F, Swart J, Quartier P, et al.
J Rheumatol
. 2022 Feb;
49(4):398-407.
PMID: 35105709
Objective: To evaluate the long-term safety profile of anakinra in patients with systemic juvenile idiopathic arthritis (sJIA). Methods: Data from patients with sJIA enrolled in the Pharmachild registry (ClinicalTrials.gov: NCT03932344)...
7.
Ruscitti P, Natoli V, Consolaro A, Caorsi R, Rosina S, Giancane G, et al.
Rheumatology (Oxford)
. 2022 Jan;
61(10):4124-4129.
PMID: 35078234
Objective: To compare clinical features and treatments of patients with systemic JIA (sIJA) and adult-onset Still's disease (AOSD). Methods: The clinical charts of consecutive patients with sJIA by International League...
8.
Kearsley-Fleet L, Klotsche J, van Straalen J, Costello W, DAngelo G, Giancane G, et al.
Rheumatology (Oxford)
. 2021 Oct;
61(6):2524-2534.
PMID: 34613385
Objectives: Burden of comorbidities are largely unknown in JIA. From 2000, national and international patient registries were established to monitor biologic treatment, disease activity and adverse events in patients with...
9.
van Straalen J, Krol R, Giancane G, Panaviene V, Ailioaie L, Dolezalova P, et al.
Rheumatology (Oxford)
. 2021 Sep;
61(5):2104-2112.
PMID: 34508559
Objective: To describe risk factors for IBD development in a cohort of children with JIA. Methods: JIA patients who developed IBD were identified from the international Pharmachild register. Characteristics were...
10.
Schiappapietra B, Bava C, Rosina S, Pistorio A, Mongelli F, Pederzoli S, et al.
Clin Exp Rheumatol
. 2021 May;
39(4):913-919.
PMID: 34001309
Objectives: To search for predictors of polyarticular extension in children with oligoarticular-onset juvenile idiopathic arthritis (JIA) and to develop a prediction model for an extended course. Methods: The clinical charts...